ScreenerHero

BGM BGM Group Ltd.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · bgmgroupltd.com
9.390USD-2.69%Mkt Cap: 125.40M $P/E: —

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segme…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap125.40M USD
Enterprise Value55.69M USD
Revenue (TTM)47.90M USD
Gross Profit6.31M USD
Net Income (TTM)-19.94M USD
Revenue/Share7.55 USD
Last Price9.390 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.02
EV/Revenue1.16
P/S2.69
P/B0.16
EPS (TTM)-4.94
EPS (Forward)—
52W Range
6.4501% of range320.25
52W High320.25 USD
52W Low6.450 USD
Profitability
Gross Margin16.64%
Oper. Margin-3.61%
EBITDA Margin-19.31%
Profit Margin-52.59%
ROE-5.10%
ROA-4.60%
Growth
Revenue Growth69.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.37M USD
CapEx (TTM)2.19M USD
FCF Margin23.46%
FCF Yield8.96%
Net Debt-10.37M USD
Net Debt/EBITDA1.12
Balance Sheet
Debt/Equity0.00
Current Ratio1.25
Quick Ratio0.53
Book Value/Sh59.55 USD
Cash/Share1.73 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateFeb 27, 2023
Pay DateMar 6, 2023
Splits
Last Split1:30
Split DateOct 1, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.69M
Float4.59M
Insiders38.05%
Institutions0.10%
Short Interest
Short Ratio0.2d
Short % Float0.02%
Short % Out.0.02%
Shares Short2.01K
Short (prev mo.)5.99K
Technical
SMA 508.275 (+13.5%)
SMA 20029.88 (-68.6%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)5.74K
Avg Vol (10d)10.25K
Technical Indicators
RSI (14)62.6
MACD0.1933
MACD Signal-0.0789
MACD Hist.+0.2721
BB Upper9.634 USD
BB Middle8.063 USD
BB Lower6.492 USD
BB Width38.97%
ATR (14)1.105 USD
Vol Ratio (20d)0.28x